Cambridge, MA · Founded 2011 · Privately Held (backing)
Developer of supramolecular therapeutics designed for cancer patients. Alyssum Therapeutics is based in Cambridge, MA and was founded in 2011. Its last reported valuation was $13.3 million in Mar 2017. It has raised $32.7 million.
Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$32.7M
Last round
—
Cap table — not yet on record
Alyssum Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alyssum Therapeutics with a free account
·Watch Alyssum Therapeutics: the Monday email on marks, rounds and moves
